INTEGRA LIFESCIENCES HOLDING (IART) Stock Price, Quote, News and Overview
NASDAQ:IART - Nasdaq - US4579852082 - Common Stock - Currency: USD
IART Quote, Performance and Key Statistics
15.19
-0.64 (-4.04%)
The current stock price of IART is 15.19 USD. In the past month the price decreased by -32.46%. In the past year, price decreased by -46.4%.
IART Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.17 | 225.27B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.89 | 167.79B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.28 | 138.41B | ||
| SYK | STRYKER CORP | 27.86 | 129.62B | ||
| MDT | MEDTRONIC PLC | 15.32 | 104.91B | ||
| BDX | BECTON DICKINSON AND CO | 14.13 | 56.45B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.41 | 40.68B | ||
| IDXX | IDEXX LABORATORIES INC | 36.15 | 32.95B | ||
| RMD | RESMED INC | 23.85 | 30.97B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.47 | 27.69B | ||
| DXCM | DEXCOM INC | 40.07 | 25.92B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 14.83 | 21.89B |
Related stock screener links
About IART
Company Profile
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,396 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The firm provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Company Info
INTEGRA LIFESCIENCES HOLDING
1100 Campus Road
Princeton NEW JERSEY 08540 US
CEO: Peter J. Arduini
Employees: 3946
Company Website: https://www.integralife.com/
Investor Relations: https://investor.integralife.com/
Phone: 16092750500
INTEGRA LIFESCIENCES HOLDING / IART FAQ
What is the stock price of INTEGRA LIFESCIENCES HOLDING today?
The current stock price of IART is 15.19 USD. The price decreased by -4.04% in the last trading session.
What is the ticker symbol for INTEGRA LIFESCIENCES HOLDING stock?
The exchange symbol of INTEGRA LIFESCIENCES HOLDING is IART and it is listed on the Nasdaq exchange.
On which exchange is IART stock listed?
IART stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INTEGRA LIFESCIENCES HOLDING stock?
18 analysts have analysed IART and the average price target is 26.78 USD. This implies a price increase of 76.27% is expected in the next year compared to the current price of 15.19. Check the INTEGRA LIFESCIENCES HOLDING stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INTEGRA LIFESCIENCES HOLDING worth?
INTEGRA LIFESCIENCES HOLDING (IART) has a market capitalization of 1.17B USD. This makes IART a Small Cap stock.
How many employees does INTEGRA LIFESCIENCES HOLDING have?
INTEGRA LIFESCIENCES HOLDING (IART) currently has 3946 employees.
What are the support and resistance levels for INTEGRA LIFESCIENCES HOLDING (IART) stock?
INTEGRA LIFESCIENCES HOLDING (IART) has a resistance level at 20.78. Check the full technical report for a detailed analysis of IART support and resistance levels.
Is INTEGRA LIFESCIENCES HOLDING (IART) expected to grow?
The Revenue of INTEGRA LIFESCIENCES HOLDING (IART) is expected to grow by 4.13% in the next year. Check the estimates tab for more information on the IART EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INTEGRA LIFESCIENCES HOLDING (IART) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IART, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IART, evaluating the profitability, health, valuation and growth aspects
- INTEGRA LIFESCIENCES HOLDING (IART) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INTEGRA LIFESCIENCES HOLDING (IART) Sales and EPS estimates to see what analysts future expectations are.
- INTEGRA LIFESCIENCES HOLDING (IART) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INTEGRA LIFESCIENCES HOLDING (IART) Insider and Institutional Ownership to learn about the owners and their transactions.
- INTEGRA LIFESCIENCES HOLDING (IART) Stock Chart to make your own analysis
- INTEGRA LIFESCIENCES HOLDING (IART) Latest news and press-releases to stay up to date.
Does INTEGRA LIFESCIENCES HOLDING (IART) stock pay dividends?
IART does not pay a dividend.
When does INTEGRA LIFESCIENCES HOLDING (IART) report earnings?
INTEGRA LIFESCIENCES HOLDING (IART) will report earnings on 2025-04-23, before the market open.
What is the Price/Earnings (PE) ratio of INTEGRA LIFESCIENCES HOLDING (IART)?
The PE ratio for INTEGRA LIFESCIENCES HOLDING (IART) is 5.93. This is based on the reported non-GAAP earnings per share of 2.56 and the current share price of 15.19 USD. Check the full fundamental report for a full analysis of the valuation metrics for IART.
What is the Short Interest ratio of INTEGRA LIFESCIENCES HOLDING (IART) stock?
The outstanding short interest for INTEGRA LIFESCIENCES HOLDING (IART) is 5.91% of its float. Check the ownership tab for more information on the IART short interest.
IART Technical Analysis
IART Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IART. While IART is still in line with the averages on profitability rating, there are concerns on its financial health.
IART Financial Highlights
Over the last trailing twelve months IART reported a non-GAAP Earnings per Share(EPS) of 2.56. The EPS decreased by -17.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.17% | ||
| ROE | -0.45% | ||
| Debt/Equity | 0.77 |
IART Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 54% to IART. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of -1.91% and a revenue growth 4.13% for IART